Telix Pharmaceuticals (TLX) Stock
Telix Pharmaceuticals (TLX) closed at $8.86 on Nov 17, 2026; its Tenet Score is 41 of 100 against 340 Healthcare peers.
41 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $8.86
- Nov 17, 2026
- 52-week range
- 6.28 – 13.11
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 41/100
- Weak · 340 Healthcare peers
Industry: Pharmaceutical Preparations
Telix Pharmaceuticals Ltd. scores 41/100. Weak. Financial health is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 41 is built from 3 of 4 pillars, from 40% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Value omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Quality Compounder
- ~ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
- ✕ Quality Floor
We are a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. Our mission is to be the global leader in radiopharmaceuticals by combining therapeutic and diagnostic m…
Common questions
What sector and industry is Telix Pharmaceuticals in?
Telix Pharmaceuticals is in the Healthcare sector and the Pharmaceutical Preparations industry.
What is Telix Pharmaceuticals' Tenet Score?
Telix Pharmaceuticals' Tenet Score is 41 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




